chr9-98807703-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024642.5(GALNT12):c.5G>T(p.Trp2Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000408 in 1,152,368 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024642.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000398 AC: 6AN: 150728Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000141 AC: 1AN: 7112Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 4458
GnomAD4 exome AF: 0.0000409 AC: 41AN: 1001640Hom.: 1 Cov.: 30 AF XY: 0.0000355 AC XY: 17AN XY: 479476
GnomAD4 genome AF: 0.0000398 AC: 6AN: 150728Hom.: 0 Cov.: 32 AF XY: 0.0000544 AC XY: 4AN XY: 73592
ClinVar
Submissions by phenotype
not provided Uncertain:2
The GALNT12 c.5G>T (p.Trp2Leu) variant has not been reported in individuals with GALNT12-related conditions in the published literature. The frequency of this variant in the general population, 0.000055 (2/36452 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
This sequence change replaces tryptophan, which is neutral and slightly polar, with leucine, which is neutral and non-polar, at codon 2 of the GALNT12 protein (p.Trp2Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GALNT12-related conditions. ClinVar contains an entry for this variant (Variation ID: 485653). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Colorectal cancer, susceptibility to, 1 Uncertain:2
- -
- -
not specified Uncertain:1
The p.W2L variant (also known as c.5G>T), located in coding exon 1 of the GALNT12 gene, results from a G to T substitution at nucleotide position 5. The tryptophan at codon 2 is replaced by leucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and leucine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. -
GALNT12-related disorder Uncertain:1
The GALNT12 c.5G>T variant is predicted to result in the amino acid substitution p.Trp2Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of African descent in gnomAD and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/485653/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at